• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

BNT162b2 与 mRNA-1273 疫苗接种者的年龄与 SARS-CoV-2 抗体反应比较。

Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine.

机构信息

Division of Allergy and Clinical Immunology, University of Virginia, Charlottesville.

出版信息

JAMA Netw Open. 2021 Sep 1;4(9):e2124331. doi: 10.1001/jamanetworkopen.2021.24331.

DOI:10.1001/jamanetworkopen.2021.24331
PMID:34473262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8414189/
Abstract

This cohort study compares antibody responses in a cohort in which both BNT162b2 and mRNA-1273 COVID-19 vaccines were administered.

摘要

本队列研究比较了同时接种 BNT162b2 和 mRNA-1273 COVID-19 疫苗的队列中的抗体反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf1/8414189/0ab2489cbdf2/jamanetwopen-e2124331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf1/8414189/0ab2489cbdf2/jamanetwopen-e2124331-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf1/8414189/0ab2489cbdf2/jamanetwopen-e2124331-g001.jpg

相似文献

1
Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine.BNT162b2 与 mRNA-1273 疫苗接种者的年龄与 SARS-CoV-2 抗体反应比较。
JAMA Netw Open. 2021 Sep 1;4(9):e2124331. doi: 10.1001/jamanetworkopen.2021.24331.
2
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.在先前感染过 SARS-CoV-2 的医护人员中，单次接种 ChAdOx1 nCoV-19 疫苗后的抗体反应。
EBioMedicine. 2021 Aug;70:103523. doi: 10.1016/j.ebiom.2021.103523. Epub 2021 Aug 12.
3
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.单剂 SARS-CoV-2 mRNA 疫苗接种后血清阳性者的抗体反应。
N Engl J Med. 2021 Apr 8;384(14):1372-1374. doi: 10.1056/NEJMc2101667. Epub 2021 Mar 10.
4
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2.先前感染过 SARS-CoV-2 的个体对 BNT162b2 mRNA 疫苗的抗体反应。
Nat Med. 2021 Jun;27(6):981-984. doi: 10.1038/s41591-021-01325-6. Epub 2021 Apr 1.
5
Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.接种BNT162b2 mRNA疫苗后，医护人员和八旬老人针对新冠病毒的年龄和性别依赖性抗体反应。
Am J Hematol. 2021 Jul 1;96(7):E257-E259. doi: 10.1002/ajh.26185. Epub 2021 Apr 24.
6
Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2).医护人员接种两剂 SARS-CoV-2 mRNA 疫苗（BNT162b2）后的早期抗体反应。
Clin Microbiol Infect. 2021 Sep;27(9):1351.e5-1351.e7. doi: 10.1016/j.cmi.2021.05.004. Epub 2021 May 8.
7
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
8
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.实体器官移植受者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗系列的抗体反应。
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.
9
Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.接受血液透析患者接种 1 剂 BNT162b2 疫苗后的短期抗体反应。
CMAJ. 2021 May 31;193(22):E793-E800. doi: 10.1503/cmaj.210673. Epub 2021 May 12.
10
Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.单剂 SARS-CoV-2 mRNA 疫苗后的抗体反应。
N Engl J Med. 2021 May 20;384(20):1959-1961. doi: 10.1056/NEJMc2102051. Epub 2021 Mar 23.

引用本文的文献

1
Humoral and Memory B Cell Responses Following SARS-CoV-2 Infection and mRNA Vaccination.新型冠状病毒2感染及mRNA疫苗接种后的体液和记忆B细胞反应
Vaccines (Basel). 2025 Jul 28;13(8):799. doi: 10.3390/vaccines13080799.
2
COVID-19 mRNA vaccine immune response to the addition of osteopathic manipulative treatment with lymphatic pumps: a randomized controlled trial.COVID-19信使核糖核酸疫苗联合淋巴泵整骨手法治疗的免疫反应：一项随机对照试验
Virus Res. 2025 Jul 14;359:199607. doi: 10.1016/j.virusres.2025.199607.
3
Systems vaccinology identifies immunological correlates of SARS-CoV-2 vaccine response in solid organ transplant recipients.

本文引用的文献

1
Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination.年龄相关的对辉瑞/生物科技 BNT162b2 冠状病毒病 2019 疫苗接种的免疫反应。
Clin Infect Dis. 2021 Dec 6;73(11):2065-2072. doi: 10.1093/cid/ciab381.
2
Quantitative Measurement of IgG to Severe Acute Respiratory Syndrome Coronavirus-2 Proteins Using ImmunoCAP.免疫捕获法定量检测 IgG 对严重急性呼吸综合征冠状病毒 2 蛋白的反应。
Int Arch Allergy Immunol. 2021;182(5):417-424. doi: 10.1159/000514203. Epub 2021 Feb 23.
3
Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021.
系统疫苗学确定了实体器官移植受者中SARS-CoV-2疫苗反应的免疫相关因素。
NPJ Vaccines. 2025 Jul 1;10(1):140. doi: 10.1038/s41541-025-01182-1.
4
Advancing ORFV-Based Therapeutics to the Clinical Stage.将基于羊口疮病毒的疗法推进到临床阶段。
Rev Med Virol. 2025 May;35(3):e70038. doi: 10.1002/rmv.70038.
5
Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects.mRNA疫苗应用中的技术突破与进展：全面探索及未来展望
Front Immunol. 2025 Mar 4;16:1524317. doi: 10.3389/fimmu.2025.1524317. eCollection 2025.
6
Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera.对人类受种者血清中mRNA-1273和BNT162b2疫苗反应的蛋白质组学和血清学评估。
Front Immunol. 2025 Jan 27;15:1502458. doi: 10.3389/fimmu.2024.1502458. eCollection 2024.
7
IPNA clinical practice recommendations on care of pediatric patients with pre-existing kidney disease during seasonal outbreak of COVID-19.国际儿科肾脏病学会（IPNA）关于新冠病毒病（COVID-19）季节性暴发期间患有基础肾脏病的儿科患者护理的临床实践建议
Pediatr Nephrol. 2025 May;40(5):1795-1815. doi: 10.1007/s00467-024-06565-5. Epub 2024 Dec 29.
8
Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico.波多黎各SARS-CoV-2 IgG抗体持久性的纵向分析。
Sci Rep. 2024 Dec 28;14(1):30743. doi: 10.1038/s41598-024-80465-4.
9
Network Analysis of Dysregulated Immune Response to COVID-19 mRNA Vaccination in Hemodialysis Patients.血液透析患者对新冠mRNA疫苗免疫反应失调的网络分析
Vaccines (Basel). 2024 Oct 7;12(10):1146. doi: 10.3390/vaccines12101146.
10
A Population-Based Study of SARS-CoV-2 IgG Antibody Responses to Vaccination in Manitoba.一项基于人群的曼尼托巴省SARS-CoV-2 IgG抗体对疫苗接种反应的研究。
Vaccines (Basel). 2024 Sep 26;12(10):1095. doi: 10.3390/vaccines12101095.
2020 年 12 月至 2021 年 1 月，以色列医护人员的真实世界数据显示，年龄、种族、性别和既往感染状况对接受一剂 BNT162b2 mRNA COVID-19 疫苗后的免疫原性有影响。
Euro Surveill. 2021 Feb;26(6). doi: 10.2807/1560-7917.ES.2021.26.6.2100096.
4
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
6
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.针对 SARS-CoV-2 感染的强大中和抗体可长期存在。
Science. 2020 Dec 4;370(6521):1227-1230. doi: 10.1126/science.abd7728. Epub 2020 Oct 28.